• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清骨硬化蛋白水平随季节变化。

Serum sclerostin levels vary with season.

机构信息

Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging (B.D.-H., S.S.H., L.C., N.J.P.), Tufts University, and Division of Endocrinology, Diabetes, and Metabolism (B.D.-H., L.C.), Tufts Medical Center, Boston, Massachusetts 02111.

出版信息

J Clin Endocrinol Metab. 2014 Jan;99(1):E149-52. doi: 10.1210/jc.2013-3148. Epub 2013 Dec 20.

DOI:10.1210/jc.2013-3148
PMID:24248178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3879665/
Abstract

CONTEXT

To establish the clinical utility of serum sclerostin levels, it is important to know whether there is seasonal variation in the measurements.

OBJECTIVE

This study was done to determine whether serum sclerostin levels vary by season in healthy older men and women.

METHODS

Serum sclerostin levels were measured in archived serum of 314 healthy men and women aged 65 years and older and examined for seasonal variation. Several factors known to vary by season and previously reported to be associated with serum sclerostin levels, including serum osteocalcin, physical activity, and serum PTH levels, were also measured in these subjects. Sex did not modify the association of season with sclerostin, so the men and women were analyzed together.

RESULTS

Serum sclerostin levels varied significantly by season (P < .001, after adjustment for sex). Sclerostin levels in the wintertime were 20% higher than the all-year mean, the levels gradually declined through the spring and summer, and by the fall, they were 20% below the all-year mean. Adjustment for serum osteocalcin, physical activity, and serum PTH did not alter the seasonal means. Seasonal differences in serum osteocalcin, physical activity, and serum PTH were not statistically significant.

CONCLUSIONS

This study documents marked seasonal variation in serum sclerostin levels. It is important to recognize this source of biological variability when considering the potential clinical utility of sclerostin measurements.

摘要

背景

为了确定血清骨硬化蛋白水平的临床实用性,了解其测量值是否存在季节性变化非常重要。

目的

本研究旨在确定健康老年男女的血清骨硬化蛋白水平是否存在季节性变化。

方法

检测了 314 名年龄在 65 岁及以上的健康男女的存档血清中的血清骨硬化蛋白水平,并检查了其季节性变化。还测量了这些受试者中已知随季节变化且先前与血清骨硬化蛋白水平相关的几个因素,包括血清骨钙素、身体活动和血清甲状旁腺激素水平。性别并未改变季节与骨硬化蛋白之间的关联,因此将男性和女性一起进行分析。

结果

血清骨硬化蛋白水平随季节显著变化(P<0.001,调整性别后)。冬季的骨硬化蛋白水平比全年平均值高 20%,春季和夏季逐渐下降,到秋季时比全年平均值低 20%。调整血清骨钙素、身体活动和血清甲状旁腺激素水平后,季节性平均值并未改变。血清骨钙素、身体活动和血清甲状旁腺激素的季节性差异无统计学意义。

结论

本研究记录了血清骨硬化蛋白水平的显著季节性变化。在考虑骨硬化蛋白测量值的潜在临床实用性时,必须认识到这种生物变异性的来源。

相似文献

1
Serum sclerostin levels vary with season.血清骨硬化蛋白水平随季节变化。
J Clin Endocrinol Metab. 2014 Jan;99(1):E149-52. doi: 10.1210/jc.2013-3148. Epub 2013 Dec 20.
2
Acute decline in serum sclerostin in response to PTH infusion in healthy men.健康男性对甲状旁腺素输注的血清硬骨素急性下降。
J Clin Endocrinol Metab. 2011 Nov;96(11):E1848-51. doi: 10.1210/jc.2011-1534. Epub 2011 Aug 24.
3
Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women.甲状旁腺激素治疗对绝经后妇女循环中骨硬化蛋白水平的影响。
J Clin Endocrinol Metab. 2010 Nov;95(11):5056-62. doi: 10.1210/jc.2010-0720. Epub 2010 Jul 14.
4
Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.循环中的 Dickkopf-1、骨保护素和硬化蛋白水平在老年人中高于年轻人,并且与老年人的全身骨矿物质密度呈正相关。
Osteoporos Int. 2017 Sep;28(9):2683-2689. doi: 10.1007/s00198-017-4104-2. Epub 2017 Jun 5.
5
Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.绝经后妇女血清硬骨素与骨密度、骨转换、类固醇和甲状旁腺激素及骨折风险的关系:OFELY 研究。
Osteoporos Int. 2013 Feb;24(2):489-94. doi: 10.1007/s00198-012-1978-x. Epub 2012 Apr 14.
6
Serum sclerostin levels in healthy men over 50 years of age.50 岁以上健康男性的血清硬骨素水平。
J Bone Miner Metab. 2013 Sep;31(5):579-84. doi: 10.1007/s00774-013-0451-z. Epub 2013 Mar 24.
7
Serum sclerostin increases in healthy adult men during bed rest.健康成年男性在卧床休息期间血清硬骨素增加。
J Clin Endocrinol Metab. 2012 Sep;97(9):E1736-40. doi: 10.1210/jc.2012-1579. Epub 2012 Jul 5.
8
Serum sclerostin levels decline in post-menopausal women with osteoporosis following treatment with intermittent parathyroid hormone.绝经后骨质疏松症患者经甲状旁腺激素间断治疗后血清骨硬化蛋白水平下降。
J Endocrinol Invest. 2012 Oct;35(9):866-8. doi: 10.3275/8522. Epub 2012 Jul 24.
9
Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.绝经后妇女的血清硬骨素水平与甲状旁腺激素水平和游离雌二醇指数呈负相关。
J Clin Endocrinol Metab. 2010 Apr;95(4):1991-7. doi: 10.1210/jc.2009-2283. Epub 2010 Feb 15.
10
Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.骨硬化蛋白及其与健康成年人的体力活动、年龄、性别、身体成分和骨矿物质含量的关系。
J Clin Endocrinol Metab. 2012 Jan;97(1):148-54. doi: 10.1210/jc.2011-2152. Epub 2011 Oct 12.

引用本文的文献

1
An In-Depth Analysis of Variable Dynamics Influencing Bone Mineral Density in Transfusion-Dependent Thalassemia Patients.对影响依赖输血的地中海贫血患者骨矿物质密度的可变动力学的深入分析。
Indian J Hematol Blood Transfus. 2025 Apr;41(2):306-314. doi: 10.1007/s12288-024-01864-1. Epub 2024 Sep 12.
2
Ethnic and seasonal variations in FGF-23 and markers of chronic kidney disease-mineral and bone disorder.成纤维细胞生长因子-23(FGF-23)以及慢性肾脏病-矿物质和骨异常标志物的种族和季节差异。
Clin Kidney J. 2024 Jun 20;17(7):sfae188. doi: 10.1093/ckj/sfae188. eCollection 2024 Jul.
3
Serum sclerostin levels as a diagnostic marker for osteoporosis.血清硬化蛋白水平作为骨质疏松症的诊断标志物
Bioinformation. 2024 Jan 31;20(1):54. doi: 10.6026/973206300200054. eCollection 2024.
4
Dual-release hydrocortisone improves body composition and the glucometabolic profile in patients with secondary adrenal insufficiency.双释放氢化可的松可改善继发性肾上腺功能不全患者的身体成分和糖代谢谱。
Endocrine. 2024 Jun;84(3):1182-1192. doi: 10.1007/s12020-024-03711-9. Epub 2024 Feb 12.
5
The effect of regular fitness training, sex hormones, and turnover of selected bone markers on sclerostin levels in young women.规律健身训练、性激素及特定骨标志物周转率对年轻女性骨硬化蛋白水平的影响。
Arch Med Sci. 2020 Oct 3;19(3):586-592. doi: 10.5114/aoms.2020.99624. eCollection 2023.
6
Relationships between Circulating Sclerostin, Bone Marrow Adiposity, Other Adipose Deposits and Lean Mass in Post-Menopausal Women.绝经后妇女循环骨硬化素与骨髓脂肪、其他脂肪沉积和瘦体重的关系。
Int J Mol Sci. 2023 Mar 21;24(6):5922. doi: 10.3390/ijms24065922.
7
Serum sclerostin levels in osteoporotic fracture patients.骨质疏松性骨折患者的血清硬骨素水平。
Eur J Trauma Emerg Surg. 2022 Dec;48(6):4857-4865. doi: 10.1007/s00068-022-02017-7. Epub 2022 Jun 16.
8
Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis.雄激素剥夺疗法对血清骨硬化蛋白、Dickkopf-1 和骨保护素水平的影响:一项横断面和纵向分析。
Sci Rep. 2021 Jul 21;11(1):14905. doi: 10.1038/s41598-021-94090-y.
9
Romosozumab: a novel bone anabolic treatment option for osteoporosis?罗莫单抗:一种用于骨质疏松症的新型骨合成代谢治疗选择?
Wien Med Wochenschr. 2020 Apr;170(5-6):124-131. doi: 10.1007/s10354-019-00721-5. Epub 2019 Dec 19.
10
Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.新型骨代谢相关激素:分析前阶段对理解其生理作用的重要性。
Endocrine. 2017 Jun;56(3):460-484. doi: 10.1007/s12020-017-1239-z. Epub 2017 Feb 8.

本文引用的文献

1
Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women.循环骨硬化蛋白与健康老年男性和女性的骨矿物质含量、微结构和转换生化标志物的关系。
J Clin Endocrinol Metab. 2013 Sep;98(9):3873-83. doi: 10.1210/jc.2013-2113. Epub 2013 Jul 17.
2
Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study.健康绝经前女性血清骨硬化蛋白、胰岛素样生长因子-1 与骨转换标志物与体力活动的关系:一项横断面研究和一项纵向研究。
J Clin Endocrinol Metab. 2012 Oct;97(10):3691-9. doi: 10.1210/jc.2011-3361. Epub 2012 Aug 3.
3
Serum sclerostin and risk of hip fracture in older Caucasian women.血清骨硬化蛋白与老年白种人女性髋部骨折风险。
J Clin Endocrinol Metab. 2012 Jun;97(6):2027-32. doi: 10.1210/jc.2011-3419. Epub 2012 Mar 30.
4
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes.1 型和 2 型糖尿病患者的循环骨硬化蛋白水平与骨转换。
J Clin Endocrinol Metab. 2012 May;97(5):1737-44. doi: 10.1210/jc.2011-2958. Epub 2012 Mar 7.
5
Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus.循环中骨硬化蛋白水平在 2 型糖尿病患者中增加。
J Clin Endocrinol Metab. 2012 Jan;97(1):234-41. doi: 10.1210/jc.2011-2186. Epub 2011 Oct 26.
6
Investigating the mechanism for maintaining eucalcemia despite immobility and anuria in the hibernating American black bear (Ursus americanus).研究美国黑熊(Ursus americanus)在休眠状态下保持血钙正常,同时出现不动和无尿的机制。
Bone. 2011 Dec;49(6):1205-12. doi: 10.1016/j.bone.2011.08.017. Epub 2011 Aug 26.
7
Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women.甲状旁腺激素治疗对绝经后妇女循环中骨硬化蛋白水平的影响。
J Clin Endocrinol Metab. 2010 Nov;95(11):5056-62. doi: 10.1210/jc.2010-0720. Epub 2010 Jul 14.
8
Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss.固定性骨丢失患者的血清硬骨素水平升高与骨形成和骨吸收标志物相关。
J Clin Endocrinol Metab. 2010 May;95(5):2248-53. doi: 10.1210/jc.2010-0067. Epub 2010 Mar 19.
9
Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.硬化蛋白通过拮抗Wnt/β-连环蛋白信号传导介导骨骼对机械卸载的反应。
J Bone Miner Res. 2009 Oct;24(10):1651-61. doi: 10.1359/jbmr.090411.
10
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.小鼠甲状旁腺激素的慢性升高会降低骨细胞中硬化蛋白的表达:一种激素控制成骨细胞生成的新机制。
Endocrinology. 2005 Nov;146(11):4577-83. doi: 10.1210/en.2005-0239. Epub 2005 Aug 4.